HLB Therapeutics Co.,Ltd.
115450
Rankning i aktier
#18257
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Aktiekurs
$2.02
Marknadsvärde
$190.66M
Förändring (1 dag)
7.96%
Förändring (1 år)
-1.16%
Land
KR
Handel HLB Therapeutics Co.,Ltd. (115450)
Kategori
Healthcare
Antal utestående aktier för HLB Therapeutics Co.,Ltd. (115450)
Antal utestående aktier per October 2026: 0
Enligt de senaste finansiella rapporterna och aktiekursen för HLB Therapeutics Co.,Ltd. är det aktuella antalet utestående aktier 0. I slutet av October 2026 hade företaget 0 utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för HLB Therapeutics Co.,Ltd. (115450) från 2016 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2025 | 83.90M | 1.29% |
| 2024 | 82.83M | 15.58% |
| 2023 | 71.66M | 8.55% |
| 2022 | 66.02M | 12.94% |
| 2021 | 58.45M | 7.26% |
| 2020 | 54.50M | 2.98% |
| 2019 | 52.92M | 7.01% |
| 2018 | 49.46M | 3.77% |
| 2017 | 47.66M | 6.05% |
| 2016 | 44.94M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
